Exploring Decentralized Clinical Trials (DCTs) - a new monthly blog series

With patient-centric trial designs becoming a driving force in the drug development industry, we will be doing a series of monthly blogs that look back on recent events which give us insight into designing resilient clinical trials and ensuring study and data continuity. For the last several months, it seems that the COVID-19 pandemic has impacted nearly every aspect of life - at home, at school and in the workplace - to create a "new normal" of social distancing and limited services. Clinical trials have been particularly impacted because of the pandemic's global scale and the need for patients and CRAs to travel and be physically present at an investigator site to complete required study activities. Patient safety, study assessments, IP administration and data integrity are becoming increasingly difficult to navigate with several sites shuttered, patients and CRAs' social distancing and the infrastructure that supports delivery of clinical trials grinding to a near halt.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/Blog/Nurse%20with%20swab.png